![Bénédicte Menn](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Bénédicte Menn
Investitore di Private Equity presso
Oxford University Innovation Ltd.
Profilo
Bénédicte Menn founded Neurokin SA in 2003, where she worked as Project Leader from 2009 to 2014.
Dr. Menn also currently works at Oxford University Innovation Ltd., as Senior Investment Manager.
Dr. Menn received her undergraduate degree in 1990 from Ecole Nationale d'Administration.
Posizioni attive di Bénédicte Menn
| Società | Posizione | Inizio |
|---|---|---|
Oxford University Innovation Ltd.
 Oxford University Innovation Ltd. Investment ManagersFinance Oxford University Innovation invests in spun out companies located in the United Kingdom. The firm targets companies operating in the fields of across a broad range of sectors and industries. It provides financing for seed and early-stage capital requirements. | Investitore di Private Equity | 01/01/2017 |
Precedenti posizioni note di Bénédicte Menn
| Società | Posizione | Fine |
|---|---|---|
Neurokin SA
 Neurokin SA BiotechnologyHealth Technology Develops kinase inhibitors for the treatment and prevention of neurological diseases like stroke and epilepsy | Fondatore | 11/03/2014 |
Formazione di Bénédicte Menn
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
21
Relazioni di 1° grado
3
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
Ecole Nationale d'Administration
 Ecole Nationale d'Administration Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oxford University Innovation Ltd.
Oxford University Innovation Ltd. Investment ManagersFinance Oxford University Innovation invests in spun out companies located in the United Kingdom. The firm targets companies operating in the fields of across a broad range of sectors and industries. It provides financing for seed and early-stage capital requirements. | Finance |
Neurokin SA
Neurokin SA BiotechnologyHealth Technology Develops kinase inhibitors for the treatment and prevention of neurological diseases like stroke and epilepsy | Health Technology |
